{
    "eid": "2-s2.0-85141385325",
    "title": "Hospital-prepared low-dose atropine eye drops for myopia progression control using atropine sulfate injection diluted in normal saline and lubricants",
    "cover-date": "2022-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Biochemistry, Genetics and Molecular Biology (all)",
            "@code": "1300",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Atropine",
        "Eyedrop",
        "Myopia"
    ],
    "authors": [
        "Nuthida Wongwirawat",
        "Nirachorn Kuchonthara",
        "Sorrawit Boontanomwong",
        "Krit Pongpirul"
    ],
    "citedby-count": 1,
    "ref-count": 13,
    "ref-list": [
        "Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050",
        "Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review",
        "Review: myopia control strategies recommendations from the 2018 WHO/IAPB/BHVI Meeting on Myopia",
        "The presence of m1 to m5 receptors in human sclera: evidence of the sclera as a potential site of action for muscarinic receptor antagonists",
        "Topical atropine in the control of myopia",
        "Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2)",
        "Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops",
        "Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: phase 2 report",
        "Stability and safety traits of novel cyclosporine A and tacrolimus ophthalmic galenic formulations involved in vernal keratoconjunctivitis treatment by a high-resolution mass spectrometry approach",
        "Stability of frozen 1% voriconazole eye-drops in both glass and innovative containers",
        "Physical, chemical, and microbiological stability study of diluted atropine eye drops",
        "Stability of ophthalmic atropine solutions for child myopia control"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60020543",
            "affilname": "Bumrungrad International Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020543",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Baltimore",
            "@id": "60006183",
            "affilname": "Johns Hopkins Bloomberg School of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006183",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Bumrungrad Clinical Research Center"
    ]
}